The cost of adverse drug events in ambulatory care.

Matthew M. Burton, Carol Hope, Michael Murray, Siu Hui, J. Marc Overhage

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

BACKGROUND: Many justifications for ePrescribing predict savings achieved by reducing the number of adverse drug events (ADEs) in the ambulatory setting however, there is little evidence from which to estimate the size of these savings. Estimating the cost of ADEs in the ambulatory setting would improve the reliability of these predictions. METHODS: We identified patients with potential ADEs in a primary care practice setting and characterized the patient's age along with charge and utilization indicators for 6 weeks pre- and post-event. We then used linear regression to determine charges attributable to an ADE. RESULTS: Charges were higher for patients following an ambulatory visit who were determined to have ADEs. This occurred in a linear fashion: 2 ADEs ($4,976); 1 ADE ($2,337); and no ADEs ($1,943). The charge attributable to a single ADE is $643 (2001 US dollars) or $926 (cost adjusted to 2006 US dollars). CONCLUSIONS: Patients with ADEs incur greater charges. The charges attributable to an ambulatory ADE are a significant cost to the health care delivery system on the order of $8 billion annually.

Original languageEnglish
Pages (from-to)90-93
Number of pages4
JournalAMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium
StatePublished - 2007

Fingerprint

Ambulatory Care
Drug-Related Side Effects and Adverse Reactions
Costs and Cost Analysis
Delivery of Health Care
Linear Models
Primary Health Care

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The cost of adverse drug events in ambulatory care. / Burton, Matthew M.; Hope, Carol; Murray, Michael; Hui, Siu; Overhage, J. Marc.

In: AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium, 2007, p. 90-93.

Research output: Contribution to journalArticle

@article{eadbd1b6de12471c8b707273721dfec4,
title = "The cost of adverse drug events in ambulatory care.",
abstract = "BACKGROUND: Many justifications for ePrescribing predict savings achieved by reducing the number of adverse drug events (ADEs) in the ambulatory setting however, there is little evidence from which to estimate the size of these savings. Estimating the cost of ADEs in the ambulatory setting would improve the reliability of these predictions. METHODS: We identified patients with potential ADEs in a primary care practice setting and characterized the patient's age along with charge and utilization indicators for 6 weeks pre- and post-event. We then used linear regression to determine charges attributable to an ADE. RESULTS: Charges were higher for patients following an ambulatory visit who were determined to have ADEs. This occurred in a linear fashion: 2 ADEs ($4,976); 1 ADE ($2,337); and no ADEs ($1,943). The charge attributable to a single ADE is $643 (2001 US dollars) or $926 (cost adjusted to 2006 US dollars). CONCLUSIONS: Patients with ADEs incur greater charges. The charges attributable to an ambulatory ADE are a significant cost to the health care delivery system on the order of $8 billion annually.",
author = "Burton, {Matthew M.} and Carol Hope and Michael Murray and Siu Hui and Overhage, {J. Marc}",
year = "2007",
language = "English",
pages = "90--93",
journal = "AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium",
issn = "1559-4076",
publisher = "American Medical Informatics Association",

}

TY - JOUR

T1 - The cost of adverse drug events in ambulatory care.

AU - Burton, Matthew M.

AU - Hope, Carol

AU - Murray, Michael

AU - Hui, Siu

AU - Overhage, J. Marc

PY - 2007

Y1 - 2007

N2 - BACKGROUND: Many justifications for ePrescribing predict savings achieved by reducing the number of adverse drug events (ADEs) in the ambulatory setting however, there is little evidence from which to estimate the size of these savings. Estimating the cost of ADEs in the ambulatory setting would improve the reliability of these predictions. METHODS: We identified patients with potential ADEs in a primary care practice setting and characterized the patient's age along with charge and utilization indicators for 6 weeks pre- and post-event. We then used linear regression to determine charges attributable to an ADE. RESULTS: Charges were higher for patients following an ambulatory visit who were determined to have ADEs. This occurred in a linear fashion: 2 ADEs ($4,976); 1 ADE ($2,337); and no ADEs ($1,943). The charge attributable to a single ADE is $643 (2001 US dollars) or $926 (cost adjusted to 2006 US dollars). CONCLUSIONS: Patients with ADEs incur greater charges. The charges attributable to an ambulatory ADE are a significant cost to the health care delivery system on the order of $8 billion annually.

AB - BACKGROUND: Many justifications for ePrescribing predict savings achieved by reducing the number of adverse drug events (ADEs) in the ambulatory setting however, there is little evidence from which to estimate the size of these savings. Estimating the cost of ADEs in the ambulatory setting would improve the reliability of these predictions. METHODS: We identified patients with potential ADEs in a primary care practice setting and characterized the patient's age along with charge and utilization indicators for 6 weeks pre- and post-event. We then used linear regression to determine charges attributable to an ADE. RESULTS: Charges were higher for patients following an ambulatory visit who were determined to have ADEs. This occurred in a linear fashion: 2 ADEs ($4,976); 1 ADE ($2,337); and no ADEs ($1,943). The charge attributable to a single ADE is $643 (2001 US dollars) or $926 (cost adjusted to 2006 US dollars). CONCLUSIONS: Patients with ADEs incur greater charges. The charges attributable to an ambulatory ADE are a significant cost to the health care delivery system on the order of $8 billion annually.

UR - http://www.scopus.com/inward/record.url?scp=56149108173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56149108173&partnerID=8YFLogxK

M3 - Article

C2 - 18693804

AN - SCOPUS:56149108173

SP - 90

EP - 93

JO - AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium

JF - AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium

SN - 1559-4076

ER -